Progesterone: the ultimate endometrial tumor suppressor

被引:146
作者
Yang, Shujie
Thiel, Kristina W.
Leslie, Kimberly K. [1 ]
机构
[1] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
BREAST-CANCER CELLS; GYNECOLOGIC-ONCOLOGY-GROUP; ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION PROFILES; EPIDERMAL GROWTH-FACTOR; DOWN-REGULATION; MEDROXYPROGESTERONE ACETATE; B-ISOFORM; TRANSCRIPTIONAL ACTIVITY; REPRODUCTIVE FUNCTIONS;
D O I
10.1016/j.tem.2011.01.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The uterine endometrium is exquisitely sensitive to steroid hormones that act through well-described nuclear receptors. Estrogen drives epithelial proliferation, and progesterone inhibits growth and causes cell differentiation. The importance of progesterone as a key inhibitor of carcinogenesis is reflected by the observation that women who ovulate and produce progesterone almost never get endometrial cancer. In this review we describe seminal research findings that define progesterone as the major endometrial tumor suppressor. We discuss the genes and diverse signaling pathways that are controlled by progesterone through progesterone receptors (PRs) and also the multiple factors that regulate progesterone/PR activity. By defining these progesterone-regulated factors and pathways we identify the principal therapeutic opportunities to control the growth of endometrial cancer.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 88 条
[71]   Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: A dose-response study by the Gynecologic Oncology Group [J].
Thigpen, JT ;
Brady, MF ;
Alvarez, RD ;
Adelson, MD ;
Homesley, HD ;
Manetta, A ;
Soper, JT ;
Given, FT .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1736-1744
[72]   A review of trafficking and activation of uterine natural killer cells [J].
van den Heuvel, MJ ;
Xie, XM ;
Tayade, C ;
Peralta, C ;
Fang, Y ;
Leonard, S ;
Paffaro, VA ;
Sheikhi, AK ;
Murrant, C ;
Croy, BA .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2005, 54 (06) :322-331
[73]   HUMAN PROGESTERONE RECEPTOR-A FORM IS A CELL-SPECIFIC AND PROMOTER-SPECIFIC REPRESSOR OF HUMAN PROGESTERONE RECEPTOR-B FUNCTION [J].
VEGETO, E ;
SHAHBAZ, MM ;
WEN, DX ;
GOLDMAN, ME ;
OMALLEY, BW ;
MCDONNELL, DP .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (10) :1244-1255
[74]   Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis [J].
Vollmer, G .
ENDOCRINE-RELATED CANCER, 2003, 10 (01) :23-42
[75]   Identification of genes differentially regulated by glucocorticoids and progestins using a Cre/loxP-mediated retroviral promoter-trapping strategy [J].
Wan, Y ;
Nordeen, SK .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2002, 28 (03) :177-192
[76]   Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cells [J].
Wan, YH ;
Nordeen, SK .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (06) :1204-1214
[77]   DNA mismatch repair deficiency accelerates endometrial tumorigenesis in pten heterozygous mice [J].
Wang, H ;
Douglas, W ;
Lia, M ;
Edelmann, W ;
Kucherlapati, R ;
Podsypanina, K ;
Parsons, R ;
Ellenson, LH .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (04) :1481-1486
[78]   Progesterone Inhibition of Wnt/β-Catenin Signaling in Normal Endometrium and Endometrial Cancer [J].
Wang, Yongyi ;
Hanifi-Moghaddam, Payman ;
Hanekamp, Eline E. ;
Kloosterboer, Helenius J. ;
Franken, Patrick ;
Veldscholte, Jos ;
van Doorn, Helena C. ;
Ewing, Patricia C. ;
Kim, J. Julie ;
Grootegoed, J. Anton ;
Burger, Curt W. ;
Fodde, Riccardo ;
Blok, Leen J. .
CLINICAL CANCER RESEARCH, 2009, 15 (18) :5784-5793
[79]   The regulation and function of the forkhead transcription factor, forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma [J].
Ward, Erin C. ;
Hoekstra, Anna V. ;
Blok, Leen J. ;
Hanifi-Moghaddam, P. ;
Lurain, John R. ;
Singh, Diljeet K. ;
Buttin, Barbara M. ;
Schink, Julian C. ;
Kim, J. Julie .
ENDOCRINOLOGY, 2008, 149 (04) :1942-1950
[80]   Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma [J].
Watanabe, J ;
Watanabe, K ;
Jobo, T ;
Kamata, Y ;
Kawaguchi, M ;
Imai, M ;
Okayasu, I ;
Kuramoto, H .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 :452-457